Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Rafael Holdings Inc
RFL | US
1.84
USD-0.11
-5.64%
RFL | US
About Rafael Holdings Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/04/2024
As of date
21/10/2024
Close
1.84
Open
1.96
High
1.96
Low
1.80
Rafael Holdings Inc. holds interests in clinical and early stage pharmaceutical companies and commercial real estate assets in the United States and Israel. It operates in two segments Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat) that is in Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia. Rafael Holdings Inc. was incorporated in 2017 and is headquartered in Newark New Jersey.
View LessRFL | US
Risk
60.9
Sharpe
-0.25
Luna's Score
51/100
Recommendation
Hold
Luna says (RFL | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
71.2%1 month
60.9%3 months
50.0%6 months
44.9%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.56
Debt to equity
0.03
Debt to assets
0.02
Ent. to EBITDA
5.39
Ent. to rev.
4.15
PEG
-
Other Fundamentals
EBITDA
-70.22M
MarketCap
45.42M
MarketCap(USD)
45.42M
Div. yield
-
Op. margin
-18.41K
Erngs. growth
-
Rev. growth
373.20
Ret. on equity
-63.51
Short ratio
1.84
Short perc.
0.43
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.70
Range1M
0.85
Range3M
1.17
Volumes: Market Activity
Rel. volume
0.31
Price X volume
42.70K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 5.39 | - | Expensive |
| Ent. to Revenue | 4.15 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.56 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 49.99 | - | Lower Risk |
| Debt to Equity | 0.03 | -1.23 | Expensive |
| Debt to Assets | 0.02 | 0.25 | Cheaper |
| Market Cap | 45.42M | - | Emerging |
